Wide Ranks

LXRX

Lexicon Pharmaceuticals, Inc.

0.8049

Top Statistics
Market Cap 290 M Forward PE -1.64 Revenue Growth 980.20 %
Current Ratio 0.00 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -0.6290 Enterprise / Revenue 25.34 Price To Sales Trailing12 Months 55.64
Profitability
Profit Margins 0.00 % Operating Margins -3639.60 %
Balance Sheet
Total Cash 258 M Total Cash Per Share 0.7150 Total Debt 99 M
Total Debt To Equity 55.96 Current Ratio 0.00 Book Value Per Share 0.4940
All Measures
Short Ratio 749.00 % Message Board Id finmb_30781 Fax 281 863 8088
Shares Short Prior Month 27 M Return On Equity -1.36 City The Woodlands
Uuid 6b83959b-e6b7-35de-9412-08dec8b7133f Previous Close 0.8202 First Trade Date Epoch Utc 955 M
Book Value 0.4940 Beta 1.24 Total Debt 99 M
Volume 2 M Price To Book 1.63 Last Split Date 1 B
Fifty Two Week Low 0.7300 Total Cash Per Share 0.7150 Total Revenue 5 M
Shares Short Previous Month Date 1 B Target Median Price 3.00 Max Age 86400
Recommendation Mean 2.00 Sand P52 Week Change 0.3133 Operating Margins -3639.60 %
Target Mean Price 4.20 Net Income To Common -216392992 Short Percent Of Float 0.1925
Implied Shares Outstanding 361 M Trailing Peg Ratio None Last Fiscal Year End 1 B
Average Daily Volume10 Day 4 M Average Volume10days 4 M Total Cash 258 M
Next Fiscal Year End 1 B Revenue Per Share 0.0180 Held Percent Insiders 0.0115
Trailing PE 0.0000 Date Short Interest 1 B Most Recent Quarter 1 B
Regular Market Previous Close 0.8202 Target Low Price 0.8000 Gmt Off Set Milliseconds -18000000
Fifty Day Average 1.48 Open 0.8100 Dividend Yield 0.00 %
State TX Return On Assets -0.4416 Time Zone Short Name EST
Trailing Eps -0.7400 Day Low 0.7910 Address1 2445 Technology Forest Boulevard
Shares Outstanding 361 M Price Hint 4 Target High Price 10.00
Website https://www.lexpharma.com 52 Week Change -0.2453 Average Volume 3 M
Forward Eps -0.6000 Recommendation Key buy Compensation As Of Epoch Date 1 B
Last Split Factor 1:7 Regular Market Day High 0.8499 Is_sp_500 False
Profit Margins 0.00 % Debt To Equity 55.96 Fifty Two Week High 3.73
Day High 0.8499 Shares Short 31 M Regular Market Open 0.8100
Industry Key biotechnology Earnings Growth 0.00 % Enterprise To Revenue 25.34
Revenue Growth 980.20 % Shares Percent Shares Out 0.0868 Currency USD
Time Zone Full Name America/New_York Market Cap 290 M Is_nasdaq_100 False
Zip 77381 Quote Type EQUITY Industry Biotechnology
Long Name Lexicon Pharmaceuticals, Inc. Regular Market Day Low 0.7910 Held Percent Institutions 0.8202
Current Price 0.8049 Address2 11th Floor Enterprise To Ebitda -0.6290
Financial Currency USD Current Ratio 0.00 Industry Disp Biotechnology
Number Of Analyst Opinions 4 Country United States Float Shares 182 M
Two Hundred Day Average 1.83 Ir Website http://www.lexpharma.com/investors/index.html Enterprise Value 132 M
Price To Sales Trailing12 Months 55.64 Forward PE -1.64 Regular Market Volume 2 M
Ebitda -210552992 Exchange NMS
Go to Yahoo Finance Go to Seeking Alpha 
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products.

Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain and LX2761, which is in Phase I clinical development for gastrointestinal tract.

Lexicon Pharmaceuticals, Inc. has strategic collaboration and license agreements with Bristol-Myers Squibb Company and Genentech, Inc. The company was incorporated in 1995 and is headquartered in The Woodlands, Texas.